Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

High-dose-rate Brachytherapy and Concurrent Chemoradiotherapy Followed by Surgery for Stage Ib-IIb Cervical Cancer: Single Institution Experience

ANA FRÖBE, GLENN JONES, TOMISLAV BOKULIĆ, IVA MRČELA, MIRJANA BUDANEC, JURE MURGIĆ, BLANKA JAKŠIĆ, MARIN PRPIĆ, ANTE BOLANČA and ZVONKO KUSIĆ
Anticancer Research July 2014, 34 (7) 3861-3866;
ANA FRÖBE
1Department of Oncology and Nuclear Medicine, University Hospital Sestre milosrdnice, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: afrobe@irb.hr
GLENN JONES
2Department of Radiation Oncology, University of Toronto, Credit Valley Hospital, Mississauga, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMISLAV BOKULIĆ
1Department of Oncology and Nuclear Medicine, University Hospital Sestre milosrdnice, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IVA MRČELA
1Department of Oncology and Nuclear Medicine, University Hospital Sestre milosrdnice, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIRJANA BUDANEC
1Department of Oncology and Nuclear Medicine, University Hospital Sestre milosrdnice, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JURE MURGIĆ
1Department of Oncology and Nuclear Medicine, University Hospital Sestre milosrdnice, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BLANKA JAKŠIĆ
1Department of Oncology and Nuclear Medicine, University Hospital Sestre milosrdnice, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIN PRPIĆ
1Department of Oncology and Nuclear Medicine, University Hospital Sestre milosrdnice, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANTE BOLANČA
1Department of Oncology and Nuclear Medicine, University Hospital Sestre milosrdnice, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ZVONKO KUSIĆ
1Department of Oncology and Nuclear Medicine, University Hospital Sestre milosrdnice, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 34 no. 7 3861-3866
PubMed 
24982415

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 20, 2014
  • Revision received May 5, 2014
  • Accepted May 7, 2014
  • Published online June 30, 2014.

Copyright & Usage 
Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. ANA FRÖBE1⇑,
  2. GLENN JONES2,
  3. TOMISLAV BOKULIĆ1,
  4. IVA MRČELA1,
  5. MIRJANA BUDANEC1,
  6. JURE MURGIĆ1,
  7. BLANKA JAKŠIĆ1,
  8. MARIN PRPIĆ1,
  9. ANTE BOLANČA1 and
  10. ZVONKO KUSIĆ1
  1. 1Department of Oncology and Nuclear Medicine, University Hospital Sestre milosrdnice, Zagreb, Croatia
  2. 2Department of Radiation Oncology, University of Toronto, Credit Valley Hospital, Mississauga, ON, Canada
  1. Correspondence to: Ana Fröbe, Department of Oncology and Nuclear Medicine, University Hospital Sestre milosrdnice, Vinogradska str. 29, 10000 Zagreb, Croatia. Tel: +385 13787468, Fax: +385 993787350, e-mail: afrobe{at}irb.hr
View Full Text

Statistics from Altmetric.com

Cited By...

  • 7 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 34 (7)
Anticancer Research
Vol. 34, Issue 7
July 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
High-dose-rate Brachytherapy and Concurrent Chemoradiotherapy Followed by Surgery for Stage Ib-IIb Cervical Cancer: Single Institution Experience
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
High-dose-rate Brachytherapy and Concurrent Chemoradiotherapy Followed by Surgery for Stage Ib-IIb Cervical Cancer: Single Institution Experience
ANA FRÖBE, GLENN JONES, TOMISLAV BOKULIĆ, IVA MRČELA, MIRJANA BUDANEC, JURE MURGIĆ, BLANKA JAKŠIĆ, MARIN PRPIĆ, ANTE BOLANČA, ZVONKO KUSIĆ
Anticancer Research Jul 2014, 34 (7) 3861-3866;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
High-dose-rate Brachytherapy and Concurrent Chemoradiotherapy Followed by Surgery for Stage Ib-IIb Cervical Cancer: Single Institution Experience
ANA FRÖBE, GLENN JONES, TOMISLAV BOKULIĆ, IVA MRČELA, MIRJANA BUDANEC, JURE MURGIĆ, BLANKA JAKŠIĆ, MARIN PRPIĆ, ANTE BOLANČA, ZVONKO KUSIĆ
Anticancer Research Jul 2014, 34 (7) 3861-3866;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Clinical Outcomes of Metastasis-directed Therapy for Oligo-metastatic Prostate Cancer Diagnosed Using PSMA-PET/CT or Whole-body MRI
  • Blood Concentrations of Osimertinib and Its Active Metabolites: Impact on Treatment Efficacy and Safety
  • Randomized Study of Short-time Continuous Saline Irrigation After Transurethral Resection in Non-muscle Invasive Bladder Cancer
Show more Clinical Studies

Similar Articles

Keywords

  • cervical cancer
  • high-dose-rate brachytherapy
  • concomitant chemoradiotherapy
  • surgery
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire